Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalyst Pharma (CPRX – Research Report), Ascendis Pharma (ASND – Research Report) and Avanos ...

Allecra – which licenses enmetazobactam from Indian drugmaker Orchid Pharma – said the approval has unlocked a five-year marketing exclusivity extension from the FDA as part of the GAIN Act ...

Bonus Sep 15, 2005 Sep 17, 2005 Jul 18, 2005 Bonus Ratio: 1 share(s) for every 2 shares held Rights Jan 09, 1995 Feb 01, 1995 Mar 15, 1995 Rights ratio: 1 share for every 1 held at a price of Rs 40.0 ...

Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is ...

The company has reported total income of Rs. 196.72 crores during the period ended March 31, 2025 as compared to Rs. 198.86 crores during the period ended December 31, 2024. The company has posted ...

The company has reported total income of Rs. 431.372 crores during the period ended March 31, 2025 as compared to Rs. 451.086 crores during the period ended December 31, 2024. The company has ...

Marksans Pharma Ltd., incorporated in the year 1992, is a Small Cap company (having a market cap of Rs 9,727.61 Crore) operating in Pharmaceuticals sector. Marksans Pharma Ltd. key Products/Revenue ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.